STOCK TITAN

[144] Atara Biotherapeutics, Inc. SEC Filing

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

ATRA submitted a notice for the settlement/sale of 13,887 shares of Common Stock on 05/15/2026, described as settlement of vested RSUs issued under an S-8 registration plan. The excerpt also shows a prior sale of 2,996 shares on 03/02/2026.

Positive

  • None.

Negative

  • None.

Insights

RSU settlement reported; routine issuer-side equity compensation activity.

The filing lists the settlement of 13,887 vested RSUs on 05/15/2026 under an S-8 registration plan, indicating compensation-related issuance rather than an open-market discretionary sale by a third party.

There is a separate line showing a prior disposition of 2,996 shares on 03/02/2026, with an accompanying numeric amount. Subsequent filings would show any resale plans or brokered transactions.

RSU settlement 13,887 shares Settlement of vested RSUs under S-8 on <date>05/15/2026</date>
Prior sale 2,996 shares Shares sold on <date>03/02/2026</date>
Associated amount <money>$15,237.36</money> Numeric amount listed adjacent to the 2,996-share sale entry
RSU financial
"Settlement of vested RSUs issued under an S-8 Registration Plan"
Restricted stock units (RSUs) are a form of company shares given to employees as part of their compensation, usually with certain restrictions or conditions, such as remaining with the company for a set period. When these restrictions lift, employees receive actual shares that they can sell or hold. For investors, RSUs can impact a company's stock supply and reflect the company's commitment to attracting and retaining talent.
S-8 registration plan regulatory
"Settlement of vested RSUs issued under an S-8 Registration Plan"
Form 144 regulatory
"Securities To Be Sold / Securities Sold During The Past 3 Months"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 for ATRA report?

The notice reports the settlement of 13,887 vested RSUs on 05/15/2026 under an S-8 registration plan. It also records a prior sale of 2,996 shares on 03/02/2026, per the excerpt.

Who receives the shares listed as settling on 05/15/2026?

The excerpt describes the transaction as equity compensation for services rendered, indicating the shares are issued to a service recipient upon RSU vesting under the S-8 plan, rather than a third-party market purchase.

Does the filing show proceeds from recent sales by insiders for ATRA?

The excerpt lists a figure of 15237.36 adjacent to a 2,996-share sale dated 03/02/2026. The filing text pairs that number with the prior sale entry, implying a monetary amount tied to that disposition.

Is the 13,887-share settlement part of a registered plan?

Yes. The settlement is described as occurring under an S-8 registration plan, indicating the shares were issued pursuant to an existing employee benefit registration on the issuer’s shelf for compensatory purposes.